Snowball logo
logo
3350

AADI BIOSCIENCES DL-0001

€3.22€0.00  (0%)
Estimate
EPS
-1.06
Beta
0.806
Growth
Net income, YoY
67.53%
FCF, YoY
71.83%
About the company
Ticker
3350
ISIN
US00032Q1040
Country
United States of America
Sector (GICS)
Healthcare
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Frequently asked questions

What sector does AADI BIOSCIENCES DL-0001 (3350) operate in?

AADI BIOSCIENCES DL-0001 belongs to the Healthcare sector and operates in the Biotechnology industry.

What is AADI BIOSCIENCES DL-0001 (3350) current stock price?

As of the latest data, AADI BIOSCIENCES DL-0001 stock price is €3.22, with a previous close of €3.22.

What is AADI BIOSCIENCES DL-0001 (3350) current market capitalization?

AADI BIOSCIENCES DL-0001 market cap is approximately 183.57 million.

What is AADI BIOSCIENCES DL-0001 (3350) Earnings Per Share (EPS)?

The trailing EPS is -€1.06.

What is AADI BIOSCIENCES DL-0001 (3350) EBITDA?

AADI BIOSCIENCES DL-0001 EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -15.85 million.

Does AADI BIOSCIENCES DL-0001 (3350) pay dividends?

No. AADI BIOSCIENCES DL-0001 does not pay a dividend.

When is AADI BIOSCIENCES DL-0001 (3350) next earnings report?

AADI BIOSCIENCES DL-0001 is expected to release its next earnings report on September 30, 2026.

What is AADI BIOSCIENCES DL-0001 (3350) beta (volatility) score?

AADI BIOSCIENCES DL-0001 has a beta of 0.806, meaning its volatility is roughly in line with the market.